Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL)

NCT01030536 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin Lymphoma
Chronic Lymphocytic Leukemia

Interventions

DRUG: CAT-8015 20 mcg/kg
DRUG: CAT-8015 30 mcg/kg
DRUG: CAT-8015 40 mcg/kg
DRUG: CAT-8015 50 mcg/kg
DRUG: CAT-8015 60 mcg/kg

Sponsor

MedImmune LLC